FluoroPharma Medical, Inc. Stock-Based Compensation
FluoroPharma Medical, Inc. reported Stock-Based Compensation of $32.45 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2017-03-31
- FluoroPharma Medical, Inc. share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $100.02K.
- FluoroPharma Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $32.45K, a 76.05% decline from fiscal 2015.
- FluoroPharma Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $135.49K, a 67.55% decline from fiscal 2014.
- FluoroPharma Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2014 was $417.57K, a 33.97% decline from fiscal 2013.
- FluoroPharma Medical, Inc. share-based payment arrangement, noncash expense for fiscal 2013 was $632.41K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|
| 2016-12-31 | $32.45K 10-K · filed 2017-03-31 | ||
| 2015-12-31 | $135.49K 10-K · filed 2017-03-31 | ||
| 2014-12-31 | $417.57K 10-K · filed 2016-03-30 | ||
| 2013-12-31 | $632.41K 10-K · filed 2015-03-31 | $180.50K 10-K · filed 2014-03-25 | |
| 2012-03-31 | $100.02K 10-Q · filed 2012-05-15 | ||
| 2011-12-31 | $1.74M 10-Q · filed 2012-05-15 |